Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Lanas, A; A García-Rodríguez, L; T Arroyo, M; Gomollón, F; Feu, F; González-Pérez, A; Zapata, E; Bástida, G; Rodrigo, L; Santolaria, S; Güell, M; M de Argila, C; Quintero, E; Borda, F; M Piqué, J; Española de Gastroenterología, Asociación

doi:10.1136/gut.2005.080754

Public

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Published in Gut • Dec 1, 2006

NobleIDark:/48914/w1/20260526/430744A9Record on NobleID

Authors:

A Lanas

,

L A García-Rodríguez

,

M T Arroyo

Abstract

BACKGROUND: The risks and benefits of coxibs, non-steroidal anti-inflammatory drugs (NSAIDs), and aspirin treatment are under intense debate. OBJECTIVE: To determine the risk of peptic ulcer upper gastrointestinal bleeding (UGIB) associated with the use of coxibs, traditional NSAIDs, aspirin or comb...

Discussions